We used shRNA, for the first time, to inactivate PRKAR1A in lung adenocarcinoma cells and observed that PRKAR1A deletion enhanced in vivo lung metastasis in nude mice. This evidence concerns the gene PRKAR1A and lung adenocarcinoma.